• Citer

Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2†.

par Piccart-Gebhart, Martine ;Hortobagyi, Gabriel N.;Campone, Mario;Pritchard, Kathleen;Lebrun, Fabienne;Ito, Y;Noguchi, Shinzaburo;Perez, A.;Rugo, Hope;Deleu, Ines;Burris, Howard A;Provencher, Louise;Neven, P;Gnant, Michael;Shtivelband, Mikhail;Wu, C;Fan, J;Feng, Wentao;Taran, Tetiana;Baselga, José
Référence Annals of oncology, 25, 12, page (2357-2362)
Publication Publié, 2014-12

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2†.
Auteur:	Piccart-Gebhart, Martine; Hortobagyi, Gabriel N.; Campone, Mario; Pritchard, Kathleen; Lebrun, Fabienne; Ito, Y; Noguchi, Shinzaburo; Perez, A.; Rugo, Hope; Deleu, Ines; Burris, Howard A; Provencher, Louise; Neven, P; Gnant, Michael; Shtivelband, Mikhail; Wu, C; Fan, J; Feng, Wentao; Taran, Tetiana; Baselga, José
Informations sur la publication:	Annals of oncology, 25, 12, page (2357-2362)
Statut de publication:	Publié, 2014-12
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	everolimus
	exemestane
	hormone-receptor-positive breast cancer
	overall survival
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0923-7534
	info:doi/10.1093/annonc/mdu456
	info:pii/mdu456
	info:scp/84921807735
	info:pmid/25231953